30 April 2025
Pharmaceutics Exceptional Reviewers List 2025


We are thrilled to share the updated Pharmaceutics Exceptional Reviewers List for 2025. This program was designed to recognize and honor scholars delivering consistently exceptional review reports to our journal. 

Committed to fostering rigorous research and promoting knowledge exchange, Pharmaceutics recognizes the significant role our reviewers play in maintaining the quality and integrity of the articles we publish. According to surveys conducted in 2024, 92% of our authors rate the peer review as good or excellent, thanks to our pool of excellent reviewers. 

We would like to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist in Pharmaceutics’ peer review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback, and contributing to academic rigor are truly commendable. 

The Exceptional Reviewers List was introduced in April 2025. Each quarter, we will be selecting a group of outstanding reviewers and introduce them here. 

Q1
Name: Dr. Jacinta O. Pinho
Affiliation: Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Campus Universitário de Santiago 3810-193 Aveiro; Portugal
Jacinta Pinho holds a Ph.D. in Pharmacy, specialty Pharmaceutical Technology, awarded by the Faculty of Pharmacy, University of Lisboa. Currently, she is a researcher at the Institute of Biomedicine (iBiMED), University of Aveiro. As a researcher and author, Jacinta interests focus on lipid-based nanosystems, cancer theranostics, methicillin-resistant Staphylococcus aureus (MRSA) infection therapy, antimicrobial resistance, and One Health approach. Jacinta often collaborates with journals as a reviewer and since 2023 has completed 34 reviews, with 6 of them for Pharmaceutics. This is a very enriching experience that provides valuable insights to both authors and reviewers, helping the scientific community to share knowledge and promote research advancements.” 

Name: Dr. Sara Demartis
Affiliation: Institute of genetic and biomedical research (IRGB), National Research Council (CNR), Sassari, Italy
Interests: skin drug delivery; skin diseases; melanoma drug delivery; rosacea drug delivery; lipid nanoparticles; liposomes 

Name: Dr. Pradeep Kumar Jaiswal
Affiliation: Texas A&M University, College Station Texas 77843, USA
Interests: medicinal chemistry; biochemistry; organocatalysis; natural product synthesis; stereoselective synthesis; electrochemistry; Ti-Li enolate chemistry; anti-infectious agents; anticancer agents; chiral methodology; nanomaterial synthesis; antitubercular agents; antimicrobial agents; antioxidant agents 

Name: Dr. Weikang Hu
Affiliation: School of Materials Science and Engineering, Hubei University, Wuhan 430062, China
Interests: 3D printing; biomaterials; electrospun nanofibers; hydrogels; regenerative medicine; biomedical polymers 

Name: Dr. Joanna Kołodziejczyk-Czepas
Affiliation: Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska, 90-236 Lodz, Poland
Interests: hemostasis; oxidative stress; antioxidants; plant-derived compounds; anticoagulants; blood platelets; biochemistry 

Name: Dr. Barbara Conway
Affiliation: Department of Pharmacy, University of Huddersfield, Huddersfield HD1 3DH, UK
Interests: pharmacy; drug delivery; formulation

Back to TopTop